INTERVIEW: GSK's West Coast drug hunter builds relationships, seeks 'quirky' science
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline has established a presence in San Diego led by Damien McDevitt to enhance the UK-based pharmaceutical company's existing partnerships on the West Coast and build new relationships with scientists, research institutes and biotechnology companies from Southern California to Seattle, Washington.